“Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats”
Article in European Journal of Pharmacology (July 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (July 2024)
Article in International Journal of Molecular Sciences (July 2024)
Article in Glia (June 2024)